CYP2C8-Mediated Drug-Drug Interactions and the Factors Influencing the Interaction Magnitude. [PDF]
Zhu LL, Yu LY, Wang YH, Zhou Q.
europepmc +1 more source
Association ofCYP2C8, CYP3A4, CYP3A5, andABCB1Polymorphisms with the Pharmacokinetics of Paclitaxel [PDF]
Anja Henningsson +11 more
openalex +1 more source
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis [PDF]
Franciszek Główka +4 more
core +1 more source
New Mechanistic Evidence for Perfluorodecanoic Acid (PFDA) Teratogenicity via CYP26A1-Mediated Retinoic Acid Metabolism and Signaling. [PDF]
Hvizdak M, Kandel SE, Lampe JN.
europepmc +1 more source
Beyond the Very Important Pharmacogenes (VIPs): Uncovering Shadow Pharmacogenes in the Human Drug Response Network. [PDF]
de Melo NC +5 more
europepmc +1 more source
RNA Editing Enzymes Modulate the Expression of Hepatic CYP2B6, CYP2C8, and Other Cytochrome P450 Isoforms [PDF]
Kaori Nozaki +4 more
openalex +1 more source
Managing Drug-Drug Interactions Involving the Non-Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling. [PDF]
Zhou Z +6 more
europepmc +1 more source
Pharmacogenetics and Molecular Ancestry of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC22A3</i>, <i>ABCB1</i>, <i>CYP2C8</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Ecuadorian Subjects with Type 2 Diabetes Mellitus. [PDF]
Ortega-Ayala A +8 more
europepmc +1 more source
Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid <i>via</i> CYP2C8
Asuna Senda +7 more
openalex +2 more sources

